Gregory Moeck Selected Research

Daptomycin

12/2015	In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
12/2009	Time-kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes.
6/2009	Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory Moeck Research Topics

Disease

10	Infections 01/2017 - 10/2008
4	Osteomyelitis 02/2010 - 10/2008
1	Sepsis (Septicemia) 01/2021
1	Clostridium Infections 12/2012
1	Endocarditis 02/2012

Drug/Important Bio-Agent (IBA)

8	oritavancinIBA 01/2017 - 10/2008
4	Vancomycin FDA LinkGeneric 12/2015 - 06/2009
4	ProdrugsIBA 02/2010 - 10/2008
3	Daptomycin FDA Link 12/2015 - 06/2009
3	Linezolid (Zyvox)FDA Link 12/2015 - 06/2009
3	LipoglycopeptidesIBA 12/2015 - 10/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2010 - 10/2008
2	TeicoplaninIBA 12/2009 - 06/2009
2	FluoroquinolonesIBA 11/2008 - 10/2008
1	carbapenemaseIBA 01/2021
1	Ceftibuten (Cedax)FDA Link 01/2021
1	GlycopeptidesIBA 02/2010
1	Penicillins (Penicillin)FDA Link 12/2009
1	Erythromycin (Erycette)FDA LinkGeneric 12/2009
1	KRM 1648IBA 12/2008
1	Diphosphonates (Bisphosphonates)IBA 11/2008
1	EstersIBA 10/2008